1. Amgen Inc.
2. EMD Serono
3. Eli Lilly and company
4. Genentech
5. Novartis AG
6. Pfizer Inc.
7. F. Hoffmann-La Roche Ltd
8. Sanofi
9. Suzhou Zelgen Biopharmaceuticals
10. Taiho Oncology
Published | Pages | Publisher | Report code |
---|---|---|---|
Oct 2023 | 190 | TechSci Research | ASDR-637929 |
1. Amgen Inc.
2. EMD Serono
3. Eli Lilly and company
4. Genentech
5. Novartis AG
6. Pfizer Inc.
7. F. Hoffmann-La Roche Ltd
8. Sanofi
9. Suzhou Zelgen Biopharmaceuticals
10. Taiho Oncology